Prevent more strokes with a daily anti-clotting heart pill
Part of Brain & nervous system, Heart & circulation clinical trials.
This Phase 3 trial tests whether a daily “polypill” can reduce the chance of another stroke after a recent ischemic stroke. It may help people by improving several heart-and-blood-vessel risks at once, but only if it fits safely with their medical situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older and able to understand and sign consent
- Have had an ischemic stroke (not bleeding in the brain) within the last 2 months
- Have at least one added heart risk condition, such as diabetes, high blood pressure, mild–moderate kidney problems, or a prior heart attack
- Not have a known reason you cannot take any part of the study “polypill”
- Not have major exclusions like hemorrhagic (bleeding) stroke, severe heart failure, or very severe kidney disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests whether a daily “polypill” plus a simple home risk-check plan can lower the chance of stroke and future thinking/memory problems. It is aimed at adults at moderate risk but who have not had stroke or heart disease before.
This trial tests if the drug cilostazol can prevent another stroke in people who have already had one. It is designed for patients in Africa and compares adding cilostazol to standard aspirin or clopidogrel therapy.
This trial tests two blood-thinning medications (sarpogrelate and clopidogrel) to see which one improves blood flow in the legs better and is safer for people who have had a stroke and also have leg pain when walking due to narrowed arteries.
This trial looks at how a daily “polypill” affects coronary (heart blood vessel) risk factors in adults who already take this polypill for prevention after a prior heart event. If you’re eligible, you’ll complete several study visits so the team can compare risk factors over time.
This trial tests a single 'polypill' that combines several medicines for people with high blood pressure, high cholesterol, and type 2 diabetes. The goal is to see if taking one pill each day helps control these conditions better than usual care.
This study tests a single pill that combines three heart medicines—aspirin, a blood thinner, and a statin—to see if it helps people who have had a heart attack or stent procedure. It aims to make it easier to take your daily heart medications.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.